openPR Logo
Press release

Phase Transfer Catalyst Market worth $1,232 million by 2023

02-19-2019 01:05 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: MarketsandMarkets.com

The report "Phase Transfer Catalyst Market by Type (Ammonium Salts, Phosphonium Salts), End-use Industry (Pharmaceuticals, Agrochemicals), and Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) - Global Forecast to 2023" The phase transfer catalyst market is expected to grow from USD 960 million in 2018 to USD 1,232 million by 2023, at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period. The major factors driving the phase transfer catalyst market include rising demand and adoption of green chemistry in organic synthesis.

Browse 49 market data Tables and 33 Figures spread through 96 Pages and in-depth TOC on "Phase Transfer Catalyst Market"

View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/phase-transfer-catalyst-market-70725388.html

Ammonium salts segment is expected to grow at the highest CAGR during the forecast period
Based on material type, the ammonium salts segment is expected to grow at the highest CAGR in the phase transfer catalyst market during the forecast period. The phase transfer catalyst market by type has been categorized into ammonium salts, phosphonium salts, and others, including crown ethers and cryptands. Ammonium salts such as tetra butyl ammonium bromide, tetrabutylammonium hydrogen sulfate, tetrabutylammonium fluoride trihydrate, and tetra butyl ammonium chloride are the most widely used phase transfer catalysts. These are easily available and inexpensive in comparison to other onium salts. In addition, ammonium salts have high demand from emerging economies in the Asia Pacific and Middle East & Africa, owing to their low cost.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=70725388

Pharmaceutical segment is expected to lead the market during the forecast period
Based on end-use industry, the pharmaceutical segment is expected to lead the phase transfer catalyst market during the forecast period. In the pharmaceutical industry, there is a high demand for green chemistry compounds in applications, such as active pharmaceutical ingredients, synthesis of drugs, and formulation of drugs or derivative compounds, among others. Moreover, in drug formulations, there is a growing demand for catalysts possessing properties, such as high reaction velocity between 2 immiscible phases, nontoxicity, and solvent waste reduction. Therefore, the pharmaceutical industry is expected to be the largest end-use industry in the phase transfer catalyst market during the forecast period.

North America is expected to account for the largest share of the phase transfer catalyst market in 2018
North America is estimated to account for the largest share of the market in 2018. The region is an established market for phase transfer catalysts owing to high capabilities for investments in R&D and facilities for the adoption of phase transfer catalysis. In addition, the US is among the largest producers and consumers of pharmaceutical and agricultural products; wherein phase transfer catalyst products are used for chemical synthesis, R&D, and formulations. This factor is fueling the growth of the phase transfer catalyst market in North America.

Major manufacturers in the phase transfer catalyst market include SACHEM Inc. (US), Tokyo Chemical Industry Co., Ltd. (Japan), Nippon Chemical Industrial Co., Ltd. (Japan), PAT IMPEX (India), Tatva Chintan Pharma Chem Pvt. Ltd. (India), and Volant-Chem Corp. (China).

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Phase Transfer Catalyst Market worth $1,232 million by 2023 here

News-ID: 1599813 • Views:

More Releases from MarketsandMarkets.com

Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players are Sika (Switzerland), BASF (Germany), MAPEI (Italy), GCP Applied Technologies (US), CEMEX (Mexico), W. R. Meadows (US)
Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players ar …
The report "Concrete Surface Retarders Market by Raw Material (Organic Agents and Inorganic Agents), Type (Water-based and Solvent-based), Application (Residential and Commercial), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023", The concrete surface retarders market is projected to grow from USD 72.7 million in 2018 to USD 89.4 million by 2023, at a CAGR of 4.2% between 2018 and 2023. Increase in urban population, demand for
Precast Concrete Market worth $174.1 billion by 2025 | Major Players are Lafarge …
The report "Precast Concrete Market by Element (Columns & Beams, Floors & Roofs, Girders, Walls & Barriers, Utility Vaults, Pipes, Paving Slabs), Construction Type, End-use Sector (Residential, Non-residential) - Global Forecast to 2025" The global precast concrete market size is projected to grow from USD 130.6 billion in 2020 to USD 174.1 billion by 2025, at a CAGR of 5.9% from 2020 to 2025. The market is projected to grow
Fire Stopping Materials Market worth $2.4 billion by 2026 : Major Players are Hi …
The report "Fire Stopping Materials Market by Type (Sealants, Mortar, Boards, Putty &Putty Pads, Cast-in Devices), by Application (Electrical, Mechanical, Plumbing), End-Use (Commercial, Industrial & Residential), and Region - Global Forecast to 2026" MarketsandMarkets: The fire stopping materials market is projected to reach USD 2.4 billion by 2026, at a CAGR of 11.6% from USD 1.4 billion in 2021. Fire stopping is a fire protection system for sealings of any

All 5 Releases


More Releases for MarketsandMarkets™

Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are